Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
37
TRDA Quote, Financials, Valuation and Earnings
Last price:
$17.60
Seasonality move
:
-24.47%
Day range:
$16.86 - $18.00
52-week range:
$11.35 - $21.79
Dividend yield:
0%
P/E ratio:
11.07x
P/S ratio:
2.95x
P/B ratio:
1.56x
Volume:
357.3K
Avg. volume:
134.3K
1-year change:
17.41%
Market cap:
$658.6M
Revenue:
$129M
EPS (TTM):
$1.59
Earnings Data
Next earnings date for TRDA
Mar 13
2025
Most recent earnings per share
-$0.35
Beat by $0.28
(Nov 5/2024)
Consensus Estimate
-$0.63
(Nov 5/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TRDA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/13/2025 | Q4 | $12.9M | -- | -- | -$0.66 | -- |
| 11/05/2024 | Q3 | $11.9M | $19.6M | -$0.35 | -$0.63 | $0.28 |
| 08/13/2024 | Q2 | $36.4M | $94.7M | $1.55 | $0.33 | $1.22 |
| 05/07/2024 | Q1 | $15.2M | $59.1M | $0.68 | -$0.47 | $1.15 |
| 03/13/2024 | Q4 | $23.7M | $41.8M | -$0.29 | -$0.14 | -$0.15 |
| 11/07/2023 | Q3 | -- | -- | $1.02 | -$0.63 | $1.65 |
| 08/08/2023 | Q2 | -- | -- | -$0.78 | -$0.60 | -$0.18 |
| 05/10/2023 | Q1 | -- | -- | -$0.21 | -$0.84 | $0.63 |
| 03/06/2023 | Q4 | -- | -- | -$0.79 | -$0.83 | $0.04 |
| 11/07/2022 | Q3 | -- | -- | -$0.80 | -- | -- |
| 08/11/2022 | Q2 | -- | -- | -$0.74 | -- | -- |
| 05/12/2022 | Q1 | -- | -- | -$0.69 | -- | -- |
| 03/15/2022 | Q4 | -- | -- | -$0.89 | -- | -- |
| 12/09/2021 | Q3 | -- | -- | -$0.51 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.48 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.41 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.42 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.34 | -- | -- |
Entrada Therapeutics Earnings Questions
-
How Much did Entrada Therapeutics Generate in Revenue Last Quarter?
Entrada Therapeutics reported $19.6M worth of top line sales in its most recent quarter.
-
Did Entrada Therapeutics Beat Earnings Last Quarter?
Entrada Therapeutics announced earnings per share of -$0.35 which represents a beat of analyst forecast a -$0.63 per share.
-
Is Entrada Therapeutics Profitable?
Entrada Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Entrada Therapeutics EPS Next Year?
Entrada Therapeutics's earnings are forecast to decrease from -$0.20 per share to -$0.06 per share next year representing a decrease of -100%.
-
When is Entrada Therapeutics's Earnings Date?
Entrada Therapeutics's next earnings date is March 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
